Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy

Assessment of minimal residual disease (MRD) is becoming a standard diagnostic tool for curable hematological malignancies such as chronic and acute myeloid leukemia. Multiple myeloma (MM) remains an incurable disease, as a major portion of patients even in complete response eventually relapse, sugg...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Valeria Ferla, Elena Antonini, Tommaso Perini, Francesca Farina, Serena Masottini, Simona Malato, Sarah Marktel, Maria Teresa Lupo Stanghellini, Cristina Tresoldi, Fabio Ciceri, Magda Marcatti
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Frontiers Media S.A. 2022-08-01
سلاسل:	Frontiers in Oncology
الموضوعات:	multiple myeloma next gene sequencing treatment strategy complete response minimal residual disease
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fonc.2022.932852/full
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!